Our data suggested that HBV-infected individuals who carry the visfatin-1535C>T TT genotype may have a lower HCC risk compared with the C-carriers (CC or CT genotypes), especially among those with Zhuang ethnicity. The gene discussed is NAMPT; the disease is hepatocellular carcinoma.